The Hedgehog signalling pathway is crucial for development, adult stem cell maintenance, 39 cell migration, and axon guidance in a wide range of organisms. During development, the 40 
formation is necessary for normal Hh secretion and graded signalling. We propose Hh 48 transport via exosomes along cytonemes as a significant mechanism for the restricted 49 distribution of a lipid-modified morphogen. 50
51

INTRODUCTION, 52
The Hh molecule acts as a morphogen to regulate growth and cell fate specification at a distance. 53
In different systems Hh is secreted from a restricted group of cells and distributed in a 54 concentration-dependent manner according to distance from the source, resulting in differential 55 activation of target genes 1 . Thus, Hh production, release, transport and reception must be kept 56 under strict spatial and temporal control to accomplish an activity gradient. Hh gradient formation 57 mechanisms have been studied extensively in the Drosophila wing imaginal disc comprising two 58 cell populations with different adhesion affinities dividing the field into a posterior (P) and an 59 anterior (A) compartment. The P compartment cells produce Hh, which moves across the A/P 60 compartment border, decreasing in concentration as it spreads away from the border to the A 61 compartment. Hh is post-translationally modified by the addition of cholesterol 2 and palmitic acid 3 62
To analyse the distribution of Hh at the ultra-structural level, immunoelectron microscopy 112 (Immuno-EM) was performed on thawed cryosections of wing discs expressing Hh-GFP. 113 Supplementary Fig 1 (A-F) shows correlative light-electron microscopy of the Hh distribution on 114 ultrathin cryosections cut orthogonal to the ventral/dorsal axis. Immunofluorescent Hh staining 115 ( Supplementary Fig. 1A ) was detected along the whole apical disc lumen and at the basolateral 116 region of the P compartment. At the EM level, apical Hh signal was found on microvilli 117 membranes ( Supplementary Fig. 1B ) whereas basolateral staining on Hh producing cells was 118 mainly detected within multivesicular bodies (MVBs) and lysosomes as well as on the basolateral 119 membranes ( Supplementary Fig. 1C ,D,E). Interestingly, Hh staining was also detected on 120 heterogeneous vesicle-like structures (size ranging from 30 to 200 nm) in basolateral extracellular 121 spaces close to the basal lamina ( Supplementary Fig. 1F ,f). To further explore the extracellular 122 distribution of Hh, wing discs expressing Hh-GFP were labelled ex vivo with an anti-GFP antibody 123 before EM processing. As shown in Fig. 4A , thawed cryosections labelled with a dual fluorescent 124 and electron-dense Fab´fragment probe showed apical staining and a basolateral punctate 125 fluorescent pattern at the P compartment, fully consistent with the punctate labelling of external 126
Hh observed at the confocal microscope (Fig. 1 ). In addition, at the EM level, immunogold 127 staining detected Hh-GFP on apical microvilli membranes (arrows in Fig. 4B-B1 ) as well as on 128 discrete regions of basolateral membranes (arrows in Fig. 4C-D) , frequently associated with cell-129 to-cell contacts (arrows in Fig. 4D ). Importantly, significant Hh labelling was detected on clusters 130 of vesicle-like structures at the basolateral extracellular spaces (arrows in Fig. 4C , E and F) and 131 some of these vesicles appear also localized in association with cell protrusions (arrows in Fig.  132 4E, insets). Finally, Immuno-EM confirmed the presence of Hh, Ihog and Disp at MVBs and 133 exovesicles ( Supplementary Fig. 1G ,H, I) in cryosections of wing discs expressing Ihog-CFP and 134
Disp-YFP, respectively. Altogether, these results support the notion that all these Hh signalling 135 pathway components share the same secretion mechanism in exovesicles at basolateral spaces. 136
Due to the size of some of these EVs (30-150 nm) and their association with MVBs, they 137 could comprise bona fide exosomes 13 , defined as extracellular vesicles enriched in cholesterol, 138 sphingomyelin, ceramide and components of membrane raft microdomains 14 . Exosomes originate 139 from MVBs and are released to the extracellular space following fusion with the plasma 140 membrane, containing proteins implicated in trafficking, membrane fusion and signalling 15 . Hh 141 has been shown to traffic from apical to basolateral plasma membranes 6-8 and this recycling 142 process might actually localize Hh in MVBs. Both processes, Hh release 8 and MVB formation, 143 require Rab5, Rab4, and Rab8 function 16, 17 . 144
Hh-loaded exovesicles in culture cells 145
Further characterization using Drosophila cultured wing disc cells, Cl8, as well as transfected S2 146 cells expressing Hh-GFP also show the presence of endogenous Hh or Hh-GFP in EVs. These 147
EVs have exosome-like features based on flotation density and protein markers ( Fig. 5 and  148 Supplementary Fig. 2A-B) . Characterization of the vesicular fraction by isopynic density gradients 149
shows co-fractioning of the Hh protein with membrane (TSG101, Rab11, Rab8 and Syntaxin), 150 and luminal (Hsp70) exosomal associated proteins 18 (Fig. 5B ) and the Hh co-receptor Ihog 151 (Supplementary Fig. 2C ). Previously, it has been described that Hh is associated to lipoproteins 152 (Drosophila apoliproteins; Lipophorins (Lp-I and Lp-II 19 ) for transport 12 . Lp-II has also been 153 detected in EV preparations in the presence of fly extracts (source of Lps in the Drosophila cell 154 culture medium) but Lp-II does not co-fractionate with Hh-containing exosomes (Fig. 5A,B) . 155
Moreover, Hh loaded EVs were able to activate the Ptc::luciferase reporter (Fig. 5C-D 
), further 156
showing that the Hh protein present in these EVs is functional. 157
Finally, interfering with proteins involved in the production/secretion of EVs, TSG101 and 158
Rab27 20-22 in Drosophila wing disc cells (Cl8 cells) leads to a significant reduction in the levels of 159
Hh protein associated to EVs (Supplementary Fig. 2D ). However, in our in vitro model, 160 interference with the ESCRT independent exosome production protein nSMase does not show a 161 significant decrease in the Hh levels within EVs (Supplementary Fig. 2D) ATPase (CG31729), TAT-5 in C. elegans shown to regulate the budding of EVs from the plasma 174 membrane (shedding vesicles/ectosomes/microparticles) 24 (Fig. 6A a-d ). All these proteins are 175 involved in EV secretion pathways and Ykt6 has also been shown to be involved in the release of 176 exosomes containing Wingless (Wg) 25 . In addition, in order to confirm the requirement of EV 177 formation during Hh signalling, we have quantified the effect of knocking down a fraction of the 178 genes identified over the long-range target Cubitus interruptus (Ci), and a significant decrease in 179 activation was also observed (Fig 6A e-h ). These experiments then endorse the necessity of the 180 molecular machinery for EV formation and release for both short-as well as long-range Hh 181
signalling. 182
To further analyse the effect of knocking down EVs production genes over Hh-loaded 183
EVs in vivo, we ectopically expressed Hh-GFP or Ihog-RFP in producing cells, quantifying the 184 visible punctate structures only in the A compartment ( Fig.6B and for methods Supplementary Fig  185   3 ). We tested RNAi treatments with a clear effect in Hh signalling ( Fig. 6A and 6 ) including the 186 ESCRT-0 protein Hrs 26 , the accessory ESCRT protein ALiX 26 , the EV component Anx B11 27 , the 187 endosomal sorting protein Rab11 implicated in EV targeting 28 , and the lipid raft component Flo2 188 also found in EVs 29 . All RNAi treatments tested result in significantly fewer Hh-GFP puncta in the 189 A compartment (Fig. 6Ba-c) , showing an effect on actual Hh secretion. Similar reduction effects 190
were also observed for Ihog-RFP puncta, confirming again the role of these genes in the 191 regulation of the Hh pathway (Fig 6Bd) . Moreover, interfering with EV production decreases the 192 externalized levels of endogenous Hh (see Fig 6Cc expressed in levels of ratio change), shown 193 by ex vivo staining after depletion only in the dorsal compartment of the disc while the ventral part 194 retains wild type conditions (Fig. 6C a-b) . Importantly, all RNAis used did not have a significant 195 apoptotic effect after treatment ( Supplementary Fig. 4A ). In addition, quantitative experiments for four of these treatments confirmed the significant reduction of targeted RNA 197 levels induced by the RNAis expression ( Supplementary Fig.4B) . 198
On the other hand, immunolabelling for total endogenous Hh levels of wing discs 199 expressing the RNAi constructs only in the dorsal compartment, and compared to the wild type 200 ventral compartment, show no significant change, excluding potential effects of RNAi treatments 201 over production or degradation of intracellular Hh (Supplementary Fig. 4C ). The only exceptions 202 to the latter observation were the RNAi treatment for the ESCRT-I component TSG101 and the 203 ESCRT-II component Vps22, which show significant accumulation of total Hh on the P 204 compartment (paired t-test, t = -5.19, df = 7, p<0.01) (Supplementary Fig. 4Cc ). However, despite 205 this accumulation both TSG101 and Vps22 RNAi treatment still lead to a reduction in the 206 extracellular levels of Hh (Fig. 6C) . Thus, and taking into account all data from RNAi treatments, 207 EV production is required for the normal release levels of Hh to the extracellular space in the wing 208 disc and consequently for the normal graded signalling pattern. 209
DISCUSSION 210
Our previous research showed a requirement for cytonemes extending from Hh producer cells 211 towards receptor cells for Hh gradient formation, while Hh was also observed in punctate 212 structures 6 . Here, we characterized these puncta confirming their EV nature and role during Hh 213 signalling. These Hh-loaded exovesicles are a heterogeneous group, differing in size and 214 potentially in origin. In vivo imaging shows puncta moving along cytonemes, suggesting a route of 215
Hh secretion and restricted dispersion where Hh-containing EVs are transported by cytonemes. 216
Nevertheless, to date we still do not know the precise mechanism used for Hh release and 217 transport along the cytoneme. Ultrastructural analysis confirmed the presence of Hh in MVBs on 218 the A compartment, supporting an ESCRT dependent route of exovesicle formation and release. 219
Thus, it is possible that MVBs fuse to the plasma membrane releasing vesicles at the same time 220 as cytonemes are elongating, and that these smaller vesicles either travel within the cytoneme 221 (that could be small MVBs) or on the cytoneme. However, live imaging of these structures also 222
shows puncta shedding directly from the cytonemes, and these might correspond to membrane-223 derived vesicles known as shedding vesicles or ectosomes/microvesicles 30 . 224
Ectosome EVs were described as bigger than exosomes and more heterogeneous in 225 size, ranging from 200 nm to greater than 1 µm in diameter, and are originated by shedding 226 preceded by the budding of small cytoplasmic protrusions, which then detach by fission of their 227 stalk 30 . Although shedding vesicles/ectosomes seem to have a different origin 31 , the mechanisms 228 of their sorting process remain obscure and might also be dependent on the ESCRT complex 24 . 229
In addition, studies have shown a crucial role for cholesterol-rich microdomains of the plasma 230 membrane for shedding vesicle formation 32 as well as for biogenesis of exosomes 14 . In our in vivo 231 experiments, we have observed a decrease in Hh signalling by knocking down Vps22, an 232
ESCRT-II complex component described as dispensable for vesicles derived directly from the 233 plasma membrane 33,34 , but required for MVB formation 35 (reviewed in 36 ) supporting an MVB 234 fusion origin. However, we have also observed a decrease in signalling and Hh release when 235 interfering with P4-ATPase (CG-31729), the Drosophila ortholog of TAT-5 specifically involved in 236 the formation of ectosomes in C. elegans 24 . Thus, as it is difficult to account for the considerable 237 differences between the two types of vesicles, the result of knocking down Vps22 and P4-ATPase 238 together with the EM data and the in vivo imaging indicate that Hh might be released in both 239 ectosomes/microvesicles and exosome-like vesicles. Determining which process might be the 240 main one regulating Hh secretion or whether both processes are linked is a future challenge. 241
In vitro, functional tests demonstrate that Hh loaded exovesicles fractionate together with 242 classical exosomal markers (Fig 5B) , and are able to activate Hh dependent transcription in cell 243 culture ( Fig 5D) . Furthermore, interference with genes involved in the formation and release of 244
EVs in vivo has a decreasing effect on the release of Hh to the extracellular space, altering the 245 Hh gradient formation during signalling (Fig 6) . In our experimental model (the Drosophila wing (105977) were 299 from the IMP Vienna Drosophila RNAi Centre (VDRC; http://stockcenter.vdrc.at). 30 hours of 300 transient expression of the UAS-constructs using Gal4; Tub-Gal80 ts drivers was achieved by 301 maintaining the fly crosses at 18ºC and inactivation of Gal80 ts at the restrictive temperature 302 (29ºC) before dissection. 303
Immunostaining of imaginal discs 304
Immunostaining was performed according to standard protocols 48 . Imaginal discs from third instar 305 larvae were fixed in 4% paraformaldehyde/PBS for 20 min at room temperature (RT) and washed 306 in PBT before incubating with PBT 0.2% BSA for blocking (1 hour at RT) and primary antibody 307 incubations (overnight at 4°C). Incubation with fluorescent secondary antibodies (1/200 Jackson 308 laboratories and Invitrogen) was performed for 2 hours at RT for posterior washing and mounting 309 in mounting media (Vectashield). Antibodies were used at the following dilutions: rabbit polyclonal 310 anti-Hh (1:800 or 1:500, raised in this work); rat monoclonal anti-Ci 50 (1:20 dilution, a gift from B. 311 Holmgren); rabbit polyclonal anti-GFP antibody (1:500, Molecular Probes, A-6455); and rabbit 312 polyclonal anti-Caspase 3 antibody (1:50 dilution, Asp-175 from Cell Signalling). The protocol for 313
the ex-vivo labelling using anti-GFP antibody is described in 46 . Imaginal discs from third instar 314 larvae were dissected on ice, transferred immediately to ice-cold M3 medium containing anti-Hh 315 
In vivo imaging of the abdomen 323
Pupae were filmed through a window in the pupal case and analysed as described previously 6 . 324
White prepupae were attached to double-sided adhesive tape to remove the operculum with 325 forceps. The prepupa was removed from the adhesive in a solution of 1 mM levamisole in water 326 and moved to a new slide mounting between three bands of Parafilm "M" arranged in a U-shape 327 to ensure minimal squashing. A total of 30 µl of 1 mM levamisole was used to surround the 328 prepupa. A coverslip was placed over the sample, and the open part of the chamber was filled 329 with 100 µl voltalef oil to ensure an oxygen supply. All imaged flies developed into pharate adults 330 and many hatched. Z-stacks of around 40 µm with a step size of 2.5 or 3 µm were recorded 331 every 150-180 seconds using a Leica SP8 confocal microscope at room temperature. 332
Supplementary Movie 4+5, N = 9; Supplementary Movie 6, N = 6. 334
Microscopy and image processing of imaginal discs 335
Laser scanning confocal microscopes (LSM510 or LSM710 Vertical; Zeiss) were used for 336 confocal fluorescence imaging of imaginal discs. ImageJ software (National Institutes of Health) 337 was used for image processing and for determining fluorescence levels. 338
Quantification of EVs and Hh levels 339
Vesicle number (Fig. 6B ) was quantified using ImageJ. A defined rectangular area of 170x75 µm 340 was chosen, which was located in the A compartment in the vicinity of the P compartment 341
( Supplementary Fig. 3A ,B). The edge limit of the P compartment cells was defined after blurring 342 of the projected image and by creating a shaped selection to delimit edges ( Supplementary Fig.  343 3a,b) also confirmed by the immuno-labelling of the A compartment Ptc expression 344 (Supplementary Fig. 3C ). Within the selection a mean filter of 1 pixel radius was used to smooth 345 the image and remove noise. To remove particles that were of low fluorescence intensity, the 346 lower threshold for pixel intensities was set to 60, whereas the upper was kept at 255. Finally, the 347 "Analyse Particles" tool was used to count puncta within 0-4.5 pixels of size ( Supplementary Fig.  348 3a,b). Quantifications were performed using individual Z slices taken every 1µm. All images were 349 treated identically. For all RNAi treatments a control for potential cell death due to RNAi treatment 350 was performed by immune-staining with anti-Caspase antibody (see Supplementary Fig. 4A) ; no 351 significant increment of cell death due to treatment was detected. 352 Levels of externalized Hh (Fig. 6C ) and total Hh (Supplementary Fig. 4C 
Quantification of gradient length 357
Gradient lengths were determined as described in 6 and then expressed as a proportion of the 358 wing pouch length (Fig. 6 A) . 359
Quantitative RTqPCR 360
The RNAis' ability to down regulate their target genes in the transgenic flies was already tested 361 by the manufacturer (BDSC Trip toolbox stocks). Four RNAi treatments were tested 362 (Supplementary Fig. 4B ). Three independent biological replicate assays were produced for 363 TSG101-, Flo2-, Rab11-, and the control EGFP-RNAi constructs, and six replicates in the case of 364 HRS-and its control EGFP-RNAi. For RNA extraction Drosophila third instar larvae expressing 365
RNAi constructs or not were collected and kept at -80ºC. Larval tissues were homogenized in 366 500µl Trizol (Invitrogen), 100µl Chloroform (Merck). After a 15 min 12000 rpm centrifugation at 367 4ºC the upper phase containing total RNA was collected and precipitated with 250µl 2,3-propanol 368 (Merck). The dry pellets were resuspended in 40µl sterile water and stored at -80ºC. For the RT-369 qPCR reaction, RNA concentration was measured using the Nanodrop ND-1000 and RNA 370 integrity was confirmed using the "Total RNA Analysis ng sensitivity (Eukaryote)" assay of the 371 Agilent 2100 bioanalyzer. cDNA was generated using Super Script III First-Strand Synthesis 372
SuperMix for qRT-PCR from Invitrogen (PN 11752250), 800 ng of total RNA were used for each 373 replicate in a final volume of 20 ul (final concentration of 40 ng/µl). qPCR reactions (95°C for 10 374 min., followed by 40 cycles of 95°C for 15sec. and 60°C for 30sec.; and 1 cycle of 95ºC for 375 15sec, 60ºC for 15sec and 95ºC for 15sec) were run on the CFX 384 (Biorad) according to the 376 manufacturer's instructions. 377
Primers used in RTqPCR: 378
Flo2_1F 5'-GGCGATGCAGCAATTATGA-3', Flo2_1R 5'-TCATCGGTTTTGGCCAGT-3', 379
Flo2_2F 5'-GACGCAAGCAGATCGAGATT-3', Flo2_2R 5'-GATGGTCTGACATTGCTTGG-3', 380
Rab11_1F 5'-GACATTGCCAAGCATCTGAC-3', Rab11_1R 5'-GTTCTGGTCGGCATGGTC-3', 381 
Statistical Analysis 391
All statistical analysis was carried out in R 51 . Data were tested for normality using Shapiro-Wilk 392 tests (data were logged for normality where required), and for homogeneity of variance using 393
Bartlett tests. 394
Models for treatment effects on gradient length 395
For the Ptc reporter a Kruskal Wallis test of gradient length against treatments related to 396 exovesicle production (Wildtype, UAS-aSmase-RNAi, UAS-Vps22-RNAi, UAS-Vps24-RNAi, UAS-397
Ykt6-RNAi, UAS-CG31729 (P4ATPase)-RNAi) (n=65) showed a significant effect of treatment 398 (Chi 2 =34.11, df=5 P<0.001). Pairwise Wilcoxon tests adjusted for multiple comparisons were 399 used to test for differences between control and each treatment (Fig. 6 
Ad). For the Ci reporter a 400
Kruskal Wallis test of gradient length against treatments related to exovesicle production 401 were used to test for differences between control and each treatment (Fig. 6Ah) . 405
Models for treatment effects on number of EVs released 406
A Kruskal Wallis test of the number of Hh-GFP puncta released for the control (UAS-Hh-GFP) 407 and ten EVs related treatments (UAS-ALIX-RNAi, UAS-AnxB11-RNAi, UAS-CG31729 408 (P4ATPase)-RNAi, UAS-Rab11-RNAi, UAS-Hrs-RNAi, UAS-Vps4-RNAi, UAS-Flo2-RNAi, UAS-409
TSG10-RNAi, UAS-YKT6-RNAi, UAS-aSmase-RNAi)(n=103)
showed a significant effect of 410 treatment (Chi 2 =54.67, df=10 P<0.001). Pairwise Wilcoxon tests adjusted for multiple 411 comparisons were used to test for significant differences between control and each treatment (Fig  412   6Bc) . 413
A Kruskal Wallis test carried out for the number of Ihog RFP puncta released for the control (UAS-414
Ihog-RFP) and seven treatments related to exosome production (UAS-Alix-RNAi, UAS-TSG101-415
RNAi, UAS-AnxB11-RNAi, UAS-Rab11-RNAi, UAS-Hrs-RNAi, UAS-Vps4-RNAi, UAS-Flo2-RNAi) 416
(n=76) showed a significant effect of treatment (Chi 2 =31.18, df=7, P<0.001). Pairwise Wilcoxon 417 tests adjusted for multiple comparisons were used to test for significant differences between 418 control and each treatment (Fig 6Bd) .. 419
Models for treatment effect on endogenous levels of external Hh 420
A paired t-test comparing the relative fluorescence (mean gray values) for WT tissue and for 421
RNAi treated tissue (UAS-TSG101-RNAi, UAS-Rab11-RNAi, UAS-Hrs-RNAi, UAS-Vps22-RNAi) 422
(n=56) showed a significant difference (t = 13.18, df = 55, P<0.001). The Ratio WT:ap was tested 423 for difference between RNAi expressing wing discs and discs without RNAi treatment or Control, 424 using Anova (F4,51=7.79, P>0.001). Tukey's Honest significant difference tests were used to test 425 for differences between control and each treatment (Fig 6Cc) . 426
Models for treatment effect on endogenous levels of total Hh 427
Paired t-tests comparing the relative fluorescence (mean gray values) for WT tissue and for RNAi 428 treated tissue (UAS-TSG101-RNAi, UAS-Hrs-RNAi, UAS-AnxB11-RNAi, UAS-Flo2-RNAi, UAS-429
Vps22-RNAi, and UAS-CG31729-RNAi (P4-ATPase) (n=49) showed non-significant differences, 430 except for the TSG101 (t = -5.19, df = 7, p<0.01) and Vps22 (t=-5.50, df=7, p<0.001) treatments. 431
The Ratio WT:ap was tested for difference between RNAi expressing wing discs (ap) and discs 432 without RNAi treatment or control (WT), using Anova (F6,42 = 11.7, p<0.001). Tukey's Honest 433 significant difference tests showed that the only significant differences with control were for 434 TSG101 (p<0.05) and Vps22 (p<0.001) (Supplementary Fig. 4Cc) . 435
Models for treatment effects on target RNA levels 436
Welch two sample T-tests comparing the normalized values for RNA expression for WT tissue 437
and for each RNAi treated tissue (UAS-TSG101-RNAi, UAS-Flo2-RNAi, UAS-Rab11-RNAi, UAS-438
Hrs-RNAi) showed significant differences between RNAi expressing larvae and larvae without 439
RNAi treatment or Control (Supplementary Fig. 4B 
Immunoelectron Microscopy 444
Larvae were inverted in PBS and fixed in 2% (w/vol) paraformaldehyde (PFA) and 0.2% (w/vol) 445 glutaraldehyde (GLA) or 4%PFA and 0.05% GLA in 0.2 M phosphate buffer (PB, pH 7.4) for 2 h 446 at room temperature and kept in 1% (w/vol) PFA in PB at 4 °C. Subsequently, wing discs were 447 dissected, embedded in 10% (w/vol) gelatine, and processed for cryosectioning. Discs were then 448 cut orthogonal to the ventral/dorsal axis on an EM FCS cryo-ultramicrotome (Leica Microsystems) 449 at -120 °C. For immunogold labelling, thawed 90-nm thick cryosections were incubated with 450 
Cell culture 485
Drosophila S2 cells stably-expressing full-length Hh fused to green fluorescent protein (S2::Hh-486 GFP) were generated using the multicistronic vector pAc5-STABLE2-Neo 53 , and cultured in 487
Schneider's medium supplemented with 10% FBS and 1% penicillin/streptomycin at 25°C. Cl8 488 cells were cultured in M3 medium containing 2.5% of FBS, 2.5% fly extract, 10 mg/ml of insulin 489 and 1% penicillin/streptomycin. Transient transfections of Cl8 cells were performed using X-490 tremeGENE transfection reagent (Roche Applied Science) following manufacturer's instructions 491 on 25 million (5 million/ml) cells and 6 µg of DNA per transfection experiment. 492
Production and isolation of EVs 493
Crude preparation of EVs from Hh-GFP transiently transfected Cl8 cells were obtained by 494 collecting 5 ml of EV-depleted media and performing differential centrifugation at 2,000 x g and 495 100,000 x g of the supernatants after 48 h transfection period. The pellets containing crude EVs 496 were resuspended. For EV production of S2::Hh-GFP and Cl8 cells, 400 million cells were 497 cultured for 48-h and 96-h, respectively, in EV-depleted media (2.5 millions/ml), and exosomes-498 enriched EVs secreted into the medium were purified as previously described 54 ; briefly, culture 499 supernatant was collected and centrifuged at 2,000 x g, 4°C, for 10 min to remove cells. The 500 resultant supernatant was subjected to filtration through 0.22 μ m pore filters, followed by 501 ultracentrifugation at 10,000 x g and 100,000 x g for 30 min and 60 min, 4°C, respectively. The 502 resulting pellets were washed with PBS and again submitted to ultracentrifugation at 100,000 x g, 503 4°C, for 60 min. Final pellets were suspended in PBS and stored at -80ºC. 504
Western blot analysis 505
A small portion (1/350th) of the supernatants obtained after 2,000 x g and 100,000 x g, and 1/5th 506 of the crude EVs preparations or of the fractions from the sucrose gradient were analysed by 507
Western-blotting. Extracts from larvae stage 3 (L3) were prepared as described 7 . SDS-sample 508 buffer was added to the samples and incubated for 5 min at 37ºC, 65ºC and 95ºC and separated 509 on 4-12% pre-casted acrylamide gels (Invitrogen, Carlsbad, CA) under non-reducing conditions. 510
Gels were transferred to PVDF membranes and blocked (5% milk and 0.05% Tween-20 in PBS) 511 for antibody incubation. Chemoluminescent detection of proteins was performed using ECL Prime 512 
Fractionation of EVs on continuous sucrose gradient 525
A continuous 0.25-2 M sucrose gradient in 20 mM HEPES (pH 7.4) was performed as described 526 in 57 . Briefly, EVs were put on top of the continuous sucrose gradient and submitted to 527 ultracentrifugation for 16 h at 210 000 × g, 4°C, in a SW40Ti swinging-bucket rotor. By using an 528 auto densi-flow density gradient fractionator (Labconco, Kansas City, MO, USA), one millilitre 529 fractions were collected from top to bottom and 20 µL of each fraction were reserved for 530 measurement of the refractive index to density determination. Each fraction was diluted with 2 mL 531 of 20 mM HEPES (pH 7.4) and ultra-centrifuged for 1 h at 100 000 × g, 4°C, in a TLA-110 rotor. 532
Supernatants were aspirated and pellets were suspended in 25 µL PBS and stored at −80°C. 533
Gene silencing in Drosophila cultured Cl8 cells 534
nSMase, TSG101 and Rab27 dsRNAs were synthesized following the protocol used at the 535 Drosophila RNAi Screening Centre (DRSC) in Boston. Briefly, DNA templates containing T7 536 promoters sequence on both ends were obtained from the DRSC and were amplified by PCR. 537
These PCR products were used for the in vitro transcription (IVT) reaction, which was carried out 538
for 16 h at 37ºC using the T7 Megascript kit from Ambion. After DNaseI (Ambion) digestion to 539 remove the template DNA, the dsRNAs were purified using RNAeasy columns (QIAGEN). Both 540 PCR-amplified DNA and purified dsRNA products were assessed by gel electrophoreses and 541 absorbance measurements of the yield. Cl8 cells were seeded in six-well plates at 2×10 6 per well 542 in 0.5 mL of FBS-free medium and 7.5μg of dsRNA were added and incubated for 1h, adding 543 then 1.5 mL of EV-depleted medium. After 48 h of incubation a new dose of dsRNA was added 544 and after another 48h of incubation the supernatants were collected and centrifuged at 2 000 x g 545 for 10 min to remove cells, then centrifuged at 100 000 × g for 1 h, 4°C, in a TLA-110 rotor. The 546 resulting pellets were suspended in 25 µL of PBS and stored at −80°C for subsequent analysis 547 by Western blotting. 548
Luciferase activity assay of Hh EVs on cultured Drosophila cells 549
Cl8 cells were transfected with ptcΔ136-GL3 Firefly responsible reporter 58 . After 24 h, cells 550 were lifted and seeded into 96-wells plate, and 8-hours later incubated with 0.2 ng/ul of Shh 551 recombinant protein (Sigma) or 1/4th of the crude EVs. After 24 h of treatment, Firefly luciferase 552 levels were measured using the Dual-Glo Luciferase Assay System (Promega) and the ratio to 553 the control (no EVs added) was calculated to give the Hh signalling activity. This was tested in 554
triplicate and significant differences were tested by a t-student test. 555
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